mothers2mothers (m2m) is excited to announce that our long-standing supporter, LGT Venture Philanthropy (LGT VP), has chosen to deepen their commitment with a new $1M grant. This non-programmatic funding will help m2m increase our scale and impact significantly.
The grant will be used to directly support our work in Malawi, and invest in new technical staff and capacity building at our Head Office. m2m will also use a portion to create a “leverage funding” pool—designed to allow us to access large-scale grants from other donors that require cost share. While the initial grant is for the 2019 calendar year, LGT VP will assess a repeat of the new grant into a multi-year engagement for 2020 and 2021.
Tom Kagerer, Investment Director at LGT Venture Philanthropy said:
“At LGT Venture Philanthropy, we provide non-programmatic financial and practical support to organisations with effective, scalable models that dramatically improve the quality of life for the less-advantaged. We first funded mothers2mothers in 2009 and have been impressed how m2m has scaled across Africa, evolved their model, maintained operational excellence, and worked with dedication to create impact at scale. We have been especially impressed with their ability to partner with governments to use—and ultimately embed—their model into health systems, which demonstrates their outstanding capabilities to provide effective, scalable solutions at high cost-efficiency. With this new grant, we are confident we will see a step change in m2m’s impact, and we are proud to partner with them on their journey to create healthy, thriving families, and an HIV-free generation.”
LGT VP’s support to m2m over the past decade has helped m2m enter new countries, improve our technical capabilities, and invest in our business development team. However, this new investment is a significant increase from their previous cumulative commitment of $2.2M over the first 10 years—and we are excited about the results it will help us deliver.
Frank Beadle de Palomo, m2m President and Chief Executive Officer added:
“In our quest to eliminate paediatric AIDS and help entire families to thrive, we aim to reach three million clients a year by 2021. To achieve this, we will need to enter at least two new countries and evolve more high-impact interventions—all while maintaining a clear focus on quality. This will directly translate into more infants born HIV-free, and more HIV-positive women living virally suppressed and healthy—paving the way to an HIV-free generation.
“LGT VP is a rare breed of donor—one prepared to invest flexibly into building the overall capacity of an organisation for impact and scale. Their support will be critical to us achieving our goals, and we hope to attract further significant support from similar forward-thinking, flexible donors. We are delighted to be entrusted with this investment and can’t wait to demonstrate the results.”